Cargando…

Cross-talk between AMPK and EGFR dependent Signaling in Non-Small Cell Lung Cancer

Lung cancers globally account for 12% of new cancer cases, 85% of these being Non Small Cell Lung Cancer (NSCLC). Therapies like erlotinib target the key player EGFR, which is mutated in about 10% of lung adenocarcinoma. However, drug insensitivity and resistance caused by second mutations in the EG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Praveen, Paurush, Hülsmann, Helen, Sültmann, Holger, Kuner, Ruprecht, Fröhlich, Holger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899720/ https://www.ncbi.nlm.nih.gov/pubmed/27279498 http://dx.doi.org/10.1038/srep27514

Ejemplares similares

Serum microRNAs as non-invasive biomarkers for cancer
por: Brase, Jan C, et al.
Publicado: (2010)

Boosting Probabilistic Graphical Model Inference by Incorporating Prior Knowledge from Multiple Sources
por: Praveen, Paurush, et al.
Publicado: (2013)

Molecular signatures in IASLC/ATS/ERS classified growth patterns of lung adenocarcinoma
por: Zabeck, Heike, et al.
Publicado: (2018)

Estimating large-scale signaling networks through nested effect models with intervention effects from microarray data
por: Fröhlich, Holger, et al.
Publicado: (2008)

Graph based fusion of miRNA and mRNA expression data improves clinical outcome prediction in prostate cancer
por: Gade, Stephan, et al.
Publicado: (2011)

Multiple layers of intratumor heterogeneity: clues to clonal evolution of non-small cell lung cancer
por: Dietz, Steffen, et al.
Publicado: (2019)

Lung Cancer Gene Signatures and Clinical Perspectives
por: Kuner, Ruprecht
Publicado: (2013)

Differential expression of apoptotic genes PDIA3 and MAP3K5 distinguishes between low- and high-risk prostate cancer
por: Pressinotti, Nicole Chui, et al.
Publicado: (2009)

Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer
por: Puri, Neelu, et al.
Publicado: (2008)

ERG Induces Epigenetic Activation of Tudor Domain-Containing Protein 1 (TDRD1) in ERG Rearrangement-Positive Prostate Cancer
por: Kacprzyk, Lukasz A., et al.
Publicado: (2013)

ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway
por: Zhao, Yang, et al.
Publicado: (2017)

Dynamic Bayesian Network Modeling of the Interplay between EGFR and Hedgehog Signaling
por: Fröhlich, Holger, et al.
Publicado: (2015)

Predicting pathway membership via domain signatures
por: Fröhlich, Holger, et al.
Publicado: (2008)

The Cross-Talk Between EGFR and E-Cadherin
por: Ramírez Moreno, Miguel, et al.
Publicado: (2022)

Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplification
por: Brase, Jan C, et al.
Publicado: (2010)

Mutation analysis of circulating plasma DNA to determine response to EGFR tyrosine kinase inhibitor therapy of lung adenocarcinoma patients
por: Riediger, Anja Lisa, et al.
Publicado: (2016)

TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling
por: Brase, Jan C, et al.
Publicado: (2011)

Characterization of Transcriptional Changes in ERG Rearrangement-Positive Prostate Cancer Identifies the Regulation of Metabolic Sensors Such as Neuropeptide Y
por: Massoner, Petra, et al.
Publicado: (2013)

Comparative Analysis of CTRP-Mediated Effects on Cardiomyocyte Glucose Metabolism: Cross Talk between AMPK and Akt Signaling Pathway
por: Li, Ling, et al.
Publicado: (2021)

Tlr9 and Beclin 1 Cross-Talk Regulates Muscle AMPK Activation in Exercise
por: Liu, Yang, et al.
Publicado: (2020)

DMU-212 against EGFR-mutant non-small cell lung cancer via AMPK/PI3K/Erk signaling pathway
por: Zhao, Xiao-Ping, et al.
Publicado: (2023)

Lung-Kidney Cross-Talk
por: Husain-Syed, Faeq, et al.
Publicado: (2019)

Metformin Overcomes Acquired Resistance to EGFR TKIs in EGFR-Mutant Lung Cancer via AMPK/ERK/NF-κB Signaling Pathway
por: Li, Ling, et al.
Publicado: (2020)

Pathways regulating the expression of the immunomodulatory protein glycodelin in non-small cell lung cancer
por: Weber, Rebecca, et al.
Publicado: (2018)

Cross-Talk in Cell Death Signaling
por: Roy, Sophie, et al.
Publicado: (2000)

Feasibility and Challenges for Sequential Treatments in ALK-Rearranged Non-Small-Cell Lung Cancer
por: Elsayed, Mei, et al.
Publicado: (2021)

Real Talk: The Inter-play Between the mTOR, AMPK, and Hexosamine Biosynthetic Pathways in Cell Signaling
por: Cork, Gentry K., et al.
Publicado: (2018)

Loss of aquaporin-4 expression and putative function in non-small cell lung cancer
por: Warth, Arne, et al.
Publicado: (2011)

Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients
por: Dietz, Steffen, et al.
Publicado: (2016)

The lung and the brain: a dangerous cross-talk
por: Pelosi, Paolo, et al.
Publicado: (2011)

Signaling pathway cross talk in Alzheimer’s disease
por: Godoy, Juan A, et al.
Publicado: (2014)

Cross-Talk in Viral Defense Signaling in Plants
por: Moon, Ju Y., et al.
Publicado: (2016)

Trans-kingdom Cross-Talk: Small RNAs on the Move
por: Knip, Marijn, et al.
Publicado: (2014)

Glioblastoma cellular cross-talk converges on NF-κB to attenuate EGFR inhibitor sensitivity
por: Zanca, Ciro, et al.
Publicado: (2017)

Excess hepsin proteolytic activity limits oncogenic signaling and induces ER stress and autophagy in prostate cancer cells
por: Willbold, Ramona, et al.
Publicado: (2019)

Correction: Excess hepsin proteolytic activity limits oncogenic signaling and induces ER stress and autophagy in prostate cancer cells
por: Willbold, Ramona, et al.
Publicado: (2020)

EGFR Signaling in Lung Fibrosis
por: Schramm, Fabian, et al.
Publicado: (2022)

Macrophage and Tumor Cell Cross-Talk Is Fundamental for Lung Tumor Progression: We Need to Talk
por: Sarode, Poonam, et al.
Publicado: (2020)

Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients
por: Janke, Florian, et al.
Publicado: (2022)

Emerging Molecular Dependencies of Mutant EGFR-Driven Non-Small Cell Lung Cancer
por: Farnsworth, Dylan A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aucf1sb72hil46c69kj5ds8aqo